Abstract
The objective of this investigation was to systematically evaluate the diagnostic accuracy of interferon-gamma release assays (IGRAs) for tuberculosis disease. Both English and Chinese databases were searched for relevant articles through January 2012. We included studies that were restricted to diagnostic applications of IGRAs in patients with active tuberculosis and excluded studies performed in the immune-compromised population. We used Meta-DiSc software to handle the data. We calculated the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and 95 % confidence interval (CI) for each study. We also calculated the pooled sensitivity, specificity, PLR, NLR, DOR, and produced forest plots and summary receiver operating characteristic (SROC) curves. A total of 61 papers (73 studies) were eligible for meta-analysis, including 36 published in English and 25 published in the Chinese language. The overall sensitivity, specificity, PLR, NLR, DOR, and 95 % CI of IGRAs were 0.85 (95 % CI: 0.84–0.86), 0.84 (95 % CI: 0.83–0.85), 7.82 (95 % CI: 6.01–10.19), 0.17 (95 % CI: 0.14–0.21), and 59.27 (95 % CI: 40.19–87.42), respectively. For ten studies evaluating T-SPOT.TB in China, the combined sensitivity, specificity, PLR, NLR, DOR, and 95 % CI were 0.88 (95 % CI: 0.86–0.91), 0.89 (95 % CI: 0.86–0.92), 8.86 (95 % CI: 5.42–14.46), 0.13 (95 % CI: 0.10–0.17), and 88.15 (95 % CI: 41.76–186.07), respectively. The SROC area under the curve (AUC) was 0.9548 (95 % CI: 0.9323–0.9773). Though IGRAs showed good sensitivity and specificity for the detection of tuberculosis in this meta-analysis, the decision to use an IGRA should be based on the local prevalence of the disease and the country guidelines, as well as resources and logistical considerations.
Similar content being viewed by others
References
Ahmad S (2010) New approaches in the diagnosis and treatment of latent tuberculosis infection. Respir Res 11:169
Weyer K, Carai S, Nunn P (2011) Viewpoint TB diagnostics: what does the world really need? J Infect Dis 204(Suppl 4):S1196–S1202
Sohn H, Minion J, Albert H, Dheda K, Pai M (2009) TB diagnostic tests: how do we figure out their costs? Expert Rev Anti Infect Ther 7(6):723–733
Jasmer RM, Nahid P, Hopewell PC (2002) Clinical practice. Latent tuberculosis infection. N Engl J Med 347(23):1860–1866
Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146(5):340–354
Kardos M, Kimball AB (2012) Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting. J Am Acad Dermatol 66(1):148–152
Holden M, Dubin MR, Diamond PH (1971) Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 285(27):1506–1509
Nash DR, Douglass JE (1980) Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. Chest 77(1):32–37
Davies PD, Pai M (2008) The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis 12(11):1226–1234
Daley CL (2010) Update in tuberculosis 2009. Am J Respir Crit Care Med 181(6):550–555
Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, Marston BJ, Huang L, Hopewell PC, Pai M (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 56(3):230–238
Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149(3):177–184
Lalvani A, Richeldi L, Kunst H (2005) Interferon gamma assays for tuberculosis. Lancet Infect Dis 5(6):322–324, author reply 325–327
Chen J, Zhang R, Wang J, Liu L, Zheng Y, Shen Y, Qi T, Lu H (2011) Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis. PLoS One 6(11):e26827
Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H (2011) The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 30(8):694–700
Sun L, Xiao J, Miao Q, Feng WX, Wu XR, Yin QQ, Jiao WW, Shen C, Liu F, Shen D, Shen AD (2011) Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis. FEMS Immunol Med Microbiol 63(2):165–173
Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D (2011) Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 15(8):1018–1032
Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, Hopewell PC, Pai M (2011) Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 204(Suppl 4):S1120–S1129
Wang L, Liu J, Chin DP (2007) Progress in tuberculosis control and the evolving public-health system in China. Lancet 369(9562):691–696
Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–660
Toft N, Nielsen SS (2009) Summary receiver operating characteristics (SROC) and hierarchical SROC models for analysis of diagnostic test evaluations of antibody ELISAs for paratuberculosis. Prev Vet Med 92(3):249–255
Sun L, Xiao J, Li H-M, Jiao W-W, Feng W-X, Wu X-R, Miao Q, Jiao A-X, Guo Y-J, Shen A-D (2010) Evaluation of the tuberculin skin test and the whole blood interferon-γ assay for the diagnosis of tuberculosis infection in children. Chin J Evid Based Pediatr 5(3):201–206
Shi R-R, Zhang G-L, Yuan X-Q, Liu X, Wang G-B (2008) Application of antigen-induced interferon-gamma assay in diagnosis of tuberculosis. Chin J Biomed Eng 14(6):441–444
Li Q-K, Wu X-Q, Yang Y-R, Liang Y, Zhang J-X, Li N, Ye L-P, Liang J-Q, Wang A-S, Zhang G-Y, Zhang T, Wang L (2010) CFP10/ESAT6 fusion protein-ELISPOT method for Mycobacterium tuberculosis infection and its diagnosis value. Chin J Zoonoses 26(6):551–554
Zhang H, Huang S-W, Luo Z-Y (2009) IFN-γ release assays for rapid diagnosis of active tuberculosis: clinical application. Chin J Nosocomiology 19(4):1898–1899
Zhan Z-H, Chen Y-Y, Yuan Y, Xiang J, Zhou J-H, Guo A-Z (2008) The appraisal in diagnosis of active pulmo-tuberculosis of rCFP-10/ESAT-6 fusion protein by ELISA. Chin J Microbiol Immunol 28(9):847–850
Li Q (2007) [Studies on detecting infection of Mycobacterium tuberculosis by enzyme-linked immunospot (ELISPOT) method]. Hebei Medical University
Wu D, Huang S, Guo A (2011) The clinical significance of γ-interferon release test for the diagnosis of Mycobacterium tuberculosis infection. Guangdong Med J 32(10):1317–1319
Liu X, Xiao H (2009) The application of γ-interferon release assays (IGRA) for the diagnosis of infection with Mycobacterium tuberculosis. J Clin Pulm Med 14(5):672–674
Xiang J, Wang YP, Xu T, Li HZ (2011) Clinical application of enzyme linked immunospot assay for diagnosis of Mycobacterium tuberculosis. J Math Med 24(1):62–63
Chen Y, Zhan Z, Guo A, Xiang J, Deng Q, Zeng Q, Du Y, Zhou J, Wei W, Tong Q, Chen H (2008) [The study of ESAT-6/CFP-10 fusion protein specific IFN-g release assay on diagnosis of active tuberculosis]. Biotechnology Bulletin 2008-S1
Shen Y (2008) [Clinical application and antigenicity of ESAT-6/CFP-10 fusion protein for diagnosis of tuberculosis]. Zhejiang University
Zhang Y, Li G, Wang W, Shi H, Hu J, Zhang G, Liu X (2008) ESAT-6-induced in vitro interferon-gamma release assay for diagnosis of tuberculosis. J Med Forum 29(23):29–31
Xiao Q, Huang X (2009) [T-SPOT.TB test for rapid detection of Mycobacterium tuberculosis infection]. Exp Lab Med 27(3):272–274
Lin C (2009) [The establishment and preliminary application of a new TB diagnostic reagents based on the whole blood cultivation of IFN-γ release assay in vitro]. Xiameng University
Huang H, Chen X-C, Yang Q-T, Liao M-F, Zhang M-X, Yu W-Y, Zhou B-P (2009) Clinical application of IFN-γ elispot in diagnosis of pulmonary tuberculosis. Acta Acad Med Jiangxi 49(4):57–59
Zhao H (2007) [The clinical application of the specific antigens of Mycobacterium tuberculosis]. China Medical University
Zhang J, Liu WL, Zhou BP, Zhang MX, Yang QT, Zhu XY, Lu J, Deng QY, Chen XC (2009) Expression of Mycobacterium tuberculosis early secretory antigenic target-6 protein and its application in detection of Mycobacterium tuberculosis antigen-specific interferon-γ response. Chin J Tuberc Respir Dis 32(1):55–59
Zhang P-Z, Ye T-S, Deng Y-C (2011) Implication of Elispot assay for diagnosis of tuberculous meningoencephalitis and III type pulmonary tuberculosis. J Clin Pulm Med 16(5):721–722
Ye LP, Hu C, Wu XQ, Liang Y, Shi B, Liu LH, Jin JG, Zhang YZ, Hu WQ, Liu MJ, Yang YR (2010) Implication of ELISPOT assay for diagnosis of tuberculosis in sputum-negative patients with hematologic diseases. Chin J Infect Chemother 10(1):44–48
Liu Y, Zhang B, Wang A, Gao H, Ji S (2007) The significance of IFN-γ secretion response in peripheral blood mononuclear cell on the diagnosis of smear-negative pulmonary tuberculosis. Chin J Tuberc Respir Dis 30(4):304–305
Sun L, Jiao W-W, Zhao S-Y, Li Z-N, Hu Y-H, Feng X-L, Li H-M, Chi W, Jiang Q-B, Jiang Z-F, Shen A-D (2008) Evaluation of ELISPOT assay for tuberculosis diagnosis in children. Labeled Immun Clin Med 15(6):349–353
Wang W (2010) [ESAT-6 antigen-induced interferon-γ in the diagnosis of tuberculosis]. Zhenzhou University
Meng C (2007) [The study of application of antigen-specific IFN-γ detection assay for the diagnosis of active TB and latent tuberculosis infection]. Fudan University
Chen X, Liao M, Zhu X, Zhang J, Chen T, Zhang M, Gu M, Zhang F, Yu W, Zhou B (2010) Clinical utility of an in-house interferon-γ Elispot assay for the diagnosis of active tuberculosis. J Chin Antituber Assoc 32(11):747–751
Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M (2008) Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int J Tuberc Lung Dis 12(1):50–56
Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, Pasvol G, Hill AV (2001) Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163(4):824–828
Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T (2005) Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24(8):529–536
Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I (2004) Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170(1):59–64
Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ (2005) Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293(22):2756–2761
Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, Yim JJ (2007) Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 132(3):959–965
Ravn P, Munk ME, Andersen AB, Lundgren B, Nielsen LN, Lillebaek T, Soerensen IJ, Andersen P, Weldingh K (2004) Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test. Scand J Infect Dis 36(6–7):499–501
Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, Reece WH, Mwinga A, Godfrey-Faussett P, Lalvani A (2002) Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16(17):2285–2293
Higuchi K, Kawabe Y, Mitarai S, Yoshiyama T, Harada N, Mori T (2009) Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol 198(1):33–37
Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, Magdorf K (2007) Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 45(3):322–328
Goletti D, Carrara S, Vincenti D, Saltini C, Rizzi EB, Schininà V, Ippolito G, Amicosante M, Girardi E (2006) Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect 12(6):544–550
Brock I, Munk ME, Kok-Jensen A, Andersen P (2001) Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 5(5):462–467
Johnson PD, Stuart RL, Grayson ML, Olden D, Clancy A, Ravn P, Andersen P, Britton WJ, Rothel JS (1999) Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 6(6):934–937
Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM (2006) Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis 6:47
Dewan PK, Grinsdale J, Kawamura LM (2007) Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 44(1):69–73
Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A (2004) Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364(9452):2196–2203
Domínguez J, Ruiz-Manzano J, De Souza-Galvão M, Latorre I, Milà C, Blanco S, Jiménez MA, Prat C, Lacoma A, Altet N, Ausina V (2008) Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol 15(1):168–171
Palazzo R, Spensieri F, Massari M, Fedele G, Frasca L, Carrara S, Goletti D, Ausiello CM (2008) Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin Vaccine Immunol 15(2):327–337
Harada N, Higuchi K, Yoshiyama T, Kawabe Y, Fujita A, Sasaki Y, Horiba M, Mitarai S, Yonemaru M, Ogata H, Ariga H, Kurashima A, Wada A, Takamori M, Yamagishi F, Suzuki K, Mori T, Ishikawa N (2008) Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 56(5):348–353
Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, Ravn P; TBNET (2008) Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32(6):1607–1615
Jafari C, Ernst M, Kalsdorf B, Greinert U, Diel R, Kirsten D, Marienfeld K, Lalvani A, Lange C (2006) Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 174(9):1048–1054
Wang JY, Chou CH, Lee LN, Hsu HL, Jan IS, Hsueh PR, Yang PC, Luh KT (2007) Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. Emerg Infect Dis 13(4):553–558
Bianchi L, Galli L, Moriondo M, Veneruso G, Becciolini L, Azzari C, Chiappini E, de Martino M (2009) Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J 28(6):510–514
Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS (2006) Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 28(1):24–30
Bua A, Molicotti P, Delogu G, Pirina P, Mura MS, Madeddu G, Franca Saba F, Maida I, Sechi LA, Zanetti S (2007) QuantiFERON TB Gold: a new method for latent tuberculosis infection. New Microbiol 30(4):477–480
Markova R, Drenska R, Minchev P, Todorova Y, Ciccozzi M, Amicosante M (2011) Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis. New Microbiol 34(1):81–85
Zhang S, Shao L, Mo L, Chen J, Wang F, Meng C, Zhong M, Qiu L, Wu M, Weng X, Zhang W (2010) Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium tuberculosis BCG-vaccinated populations. Clin Vaccine Immunol 17(12):1985–1990
Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O (2010) Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 10:57
Lee HM, Shin JW, Kim JY, Park IW, Choi BW, Choi JC, Seo JS, Kim CW (2010) HRCT and whole-blood interferon-gamma assay for the rapid diagnosis of smear-negative pulmonary tuberculosis. Respiration 79(6):454–460
Bamford AR, Crook AM, Clark JE, Nademi Z, Dixon G, Paton JY, Riddell A, Drobniewski F, Riordan A, Anderson ST, Williams A, Walters S, Kampmann B (2010) Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child 95(3):180–186
Cruz AT, Geltemeyer AM, Starke JR, Flores JA, Graviss EA, Smith KC (2011) Comparing the tuberculin skin test and T-SPOT.TB blood test in children. Pediatrics 127(1):e31–e38
Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC (2008) A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS One 3(7):e2624
Lui G, Lee N, Cheung SW, Lam JS, Wong BC, Choi KW, Wong KT, Wong RY, Cockram CS, Hui DS, Chan RC (2011) Interferon gamma release assay for differentiating tuberculosis among pneumonia cases in acute healthcare setting. J Infect 62(6):440–447
Winqvist N, Björkman P, Norén A, Miörner H (2009) Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area. BMC Infect Dis 9:105
Taki-Eddin L, Monem F (2012) Utility of an interferon-gamma release assay as a potential diagnostic aid for active pulmonary tuberculosis. J Infect Dev Ctries 6(1):67–72
Warier A, Gunawathi S, Venkatesh, John KR, Bose A (2010) T-cell assay as a diagnostic tool for tuberculosis. Indian Pediatr 47(1):90–92
Nicol MP, Davies MA, Wood K, Hatherill M, Workman L, Hawkridge A, Eley B, Wilkinson KA, Wilkinson RJ, Hanekom WA, Beatty D, Hussey G (2009) Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 123(1):38–43
Zhang SL, Zhao JW, Sun ZQ, Yang EZ, Yan JH, Zhao Q, Zhang GL, Zhang HM, Qi YM, Wang HH, Sun QW (2009) Development and evaluation of a novel multiple-antigen ELISA for serodiagnosis of tuberculosis. Tuberculosis (Edinb) 89(4):278–284
Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356(9235):1099–1104
Okada K, Mao TE, Mori T, Miura T, Sugiyama T, Yoshiyama T, Mitarai S, Onozaki I, Harada N, Saint S, Kong KS, Chhour YM (2008) Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect 136(9):1179–1187
Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ, Reece WH, Latif M, Pasvol G, Hill AV (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357(9273):2017–2021
Nahid P, Pai M, Hopewell PC (2006) Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 3(1):103–110
Rothel JS, Jones SL, Corner LA, Cox JC, Wood PR (1990) A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle. Aust Vet J 67(4):134–137
Mazurek GH, Villarino ME; CDC (2003) Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 52(RR-2):15–18
Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC) (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54(RR-15):49–55
Dheda K, Pooran A, Pai M, Miller RF, Lesley K, Booth HL, Scott GM, Akbar AN, Zumla A, Rook GA (2007) Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J Infect 55(2):169–173
Connell T, Bar-Zeev N, Curtis N (2006) Early detection of perinatal tuberculosis using a whole blood interferon-gamma release assay. Clin Infect Dis 42(11):e82–e85
Canadian Tuberculosis Committee (CTC) (2008) Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 34(ACS-6):1–13
Drobniewski F, Cobelens F, Zellweger JP; KNCV/EuroTB Workshop (2007) Use of Gamma-interferon assays in low- and medium-prevalence countries in Europe: a consensus statement of a Wolfheze Workshop organised by KNCV/EuroTB, Vilnius Sept 2006. Euro Surveill 12(7):E070726.2
Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM; Cochrane Diagnostic Test Accuracy Working Group (2008) Systematic reviews of diagnostic test accuracy. Ann Intern Med 149(12):889–897
Jones CM, Athanasiou T (2005) Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 79(1):16–20
Davey Smith G, Egger M, Phillips AN (1997) Meta-analysis. Beyond the grand mean? BMJ 315(7122):1610–1614
Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM (1999) Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282(11):1061–1066
Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM (2006) Evidence of bias and variation in diagnostic accuracy studies. CMAJ 174(4):469–476
Acknowledgments
This study is partly supported by the National Natural Science Foundation of China (81072351), National S&T Major Project Foundation of China (2011ZX10004-902), Jiangsu Science Supported Planning/Social Development Foundation (BE2011841), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). We thank Professor Kathryn DeRiemer (University of California, Davis, CA, USA) for providing feedback on an earlier version of the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yaoyao Dai and Yan Feng contributed equally to this paper.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 504 kb)
Rights and permissions
About this article
Cite this article
Dai, Y., Feng, Y., Xu, R. et al. Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis. Eur J Clin Microbiol Infect Dis 31, 3127–3137 (2012). https://doi.org/10.1007/s10096-012-1674-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1674-y